TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cochlear ( (AU:COH) ) just unveiled an announcement.
Cochlear Limited announced a change in the director’s interest notice, where Christine Frances McLoughlin transferred 1,900 shares from C F McLoughlin Super Investments Pty Ltd to Dundas Street Investments Pty Ltd. This off-market transfer reflects an internal reallocation of shares, with no net change in the total number of shares held by the director, potentially indicating strategic financial management within the company.
The most recent analyst rating on (AU:COH) stock is a Hold with a A$327.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited operates in the medical device industry, specializing in implantable hearing solutions. The company’s primary products include cochlear implants, bone conduction implants, and acoustic implants, with a focus on improving the quality of life for individuals with hearing loss.
YTD Price Performance: 4.86%
Average Trading Volume: 178,382
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$19.72B
Find detailed analytics on COH stock on TipRanks’ Stock Analysis page.